Atualizado
APTOSE BIOSCIENCES INC - NASDAQ: $APTO Rounding Bottom
Since October, shares of APTOSE BIOSCIENCES INC - NASDAQ:APTO appear to be forming a rounding bottom and recently, have witnessed the recapture of its 200 DMA as well as a noticeable pick-up in volume as we can observe from the Daily chart above.
In addition, APTO now finds itself trading above all of its important moving averages 20/50/200 DMA's, which is suggestive of a healthy technical posture.
While further work is required, both investors/traders may want to continue to monitor the action closely and in particular, should APTO be capable of taking-out the $2.45 figure at any point in the days/weeks ahead, such development may just trigger its next advance into higher ground with and initial $3 - $3.50 objective.
Nonetheless, the recent action in APTO is encouraging and both investors/traders may want to put the name front-and-center on their radars for further clues/evidence that things may be about to pick-up n earnest.
In addition, APTO now finds itself trading above all of its important moving averages 20/50/200 DMA's, which is suggestive of a healthy technical posture.
While further work is required, both investors/traders may want to continue to monitor the action closely and in particular, should APTO be capable of taking-out the $2.45 figure at any point in the days/weeks ahead, such development may just trigger its next advance into higher ground with and initial $3 - $3.50 objective.
Nonetheless, the recent action in APTO is encouraging and both investors/traders may want to put the name front-and-center on their radars for further clues/evidence that things may be about to pick-up n earnest.
Trade ativo
APTO delivers 138% gains in 6 months.Congrats to all who participated!
For real-time alerts, signup link in bio and bottom of chart.
Aviso legal
As informações e publicações não se destinam a ser, e não constituem, conselhos ou recomendações financeiras, de investimento, comerciais ou de outro tipo fornecidos ou endossados pela TradingView. Leia mais nos Termos de Uso.
Aviso legal
As informações e publicações não se destinam a ser, e não constituem, conselhos ou recomendações financeiras, de investimento, comerciais ou de outro tipo fornecidos ou endossados pela TradingView. Leia mais nos Termos de Uso.